Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

New Treatments in Acute Myeloid Leukemia

January 9th 2015

Role of Transplant in Acute Myeloid Leukemia

January 9th 2015

Therapeutic Targets in Acute Lymphoblastic Leukemia

January 9th 2015

CAR-Modified T Cell Therapy in ALL

January 9th 2015

Blinatumomab in Acute Lymphoblastic Leukemia

January 9th 2015

Minimum Residual Disease in ALL

January 9th 2015

Asparaginase in Acute Lymphoblastic Leukemia

January 9th 2015

Chemotherapy Regimens in Patients With ALL

January 9th 2015

TKIs in Philadelphia Chromosome-Positive ALL

January 9th 2015

Vincristine in Acute Lymphoblastic Leukemia

January 9th 2015

Identifying Transplant Candidates in ALL

January 9th 2015

Induction Therapy in Adult Ph-negative ALL

January 9th 2015

Introduction: Understanding ALL and Its Prognostic Factors

January 9th 2015

Dr. Advani Compares Inotuzumab and Blinatumomab for ALL

January 8th 2015

Anjali Advani, MD ,staff physician, Department of Hematologic Oncology and Blood Disorders, Director, Inpatient Leukemia Program, Taussig Cancer Institute, associate professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, compares inotuzumab ozogamicin, a CD22 monoclonal antibody, to blinatumomab, a CD19 bi-specific anti-CD19/CD3 antibody for the treatment of acute lymphoblastic leukemia (ALL).

A Keen Mind and a Daring Spirit Propel Kantarjian's Many Discoveries in Leukemia Therapy

January 8th 2015

Hagop M. Kantarjian, MD, has built the nation's largest clinical leukemia practice, in part to ensure that leukemia studies are completed efficiently and in a timely manner.

A Day in the Life of a Military Hematology/ Oncology Fellow

December 30th 2014

At 5:45 am, the alarm on my phone goes off. I have 20 minutes until my 2 boys wake up, which is just enough time to get ready for work and fix myself a cup of coffee.

Changing Landscape in the Treatment of Relapsed/Refractory Hodgkin Lymphoma

December 29th 2014

Newer drugs for patients with relapsed and refractory Hodgkin lymphoma

Optimal Rituximab Dose in Lymphoma

December 24th 2014

Rituximab dose should be based on age and sex.

How a Bold Thinker Helped Introduce Chemotherapy Combinations to Cancer Therapy

December 21st 2014

When Vincent T. DeVita Jr, MD, began testing a cocktail of four chemotherapies against advanced Hodgkin disease back in 1964, the disease was uniformly fatal.

HCI Connects Precision Medicine With Patient-Centered Care

December 19th 2014